Figure 7.Schematic diagram illustrates the process whereby IL-17 treatment promotes IL-18 production in OASFs. IL-17 treatment upregulates levels of IL-18 expression in OASFs via MEK and ERK signaling and downregulates levels of miR-4492. IL-18 production elicits inflammatory responses during OA progression.
